Jean-Marc Holder

Passionate about harnessing innovation to solve challenges facing society

[SeqOne @seqonegenomics]

Case Study: North West GLH Validation and Implementation of In-House HRD testing with SeqOne’s SomaHRD

The NHS North West Genomic Laboratory Hub has successfully validated and implemented SeqOne's HRD platform for ovarian cancer testing, bringing cutting-edge diagnostics in-house. The results?
✅ Quicker turnaround times
✅ Greater control over testing processes
✅ Enhanced confidence through SeqOne's transparent, whitebox approach

Validated on PAOLA1, SeqOne’s HRD pipeline SomaHRD flexibly integrates with existing workflows, offering 96% concordance with the industry-standard test, and is validated across multiple wetlabs and sequencers.

🔍 Dive deeper into our comprehensive case study to discover:
• The validation process using real world FFPE tumor specimens, with results compared to Myriad myChoice™
• Detailed performance metrics and clinical outcomes
• How SeqOne's solution integrates with existing workflows

📚 Read the full case study and download our HRD white paper: https://t.co/4q64Ikq9qA

💡 Are you looking to enhance your lab's genomic testing capabilities? SeqOne's SomaHRD could be the solution you need. We offer free training and testing, let’s connect!

#ESPCongress #ECPCongress #ECP2024 #HRD #NGS

[The Economist @TheEconomist]

Beef emits 31 times more CO₂ per calorie of food than tofu does. By cooking so many cows, we are cooking ourselves, too. Forgoing steaks may be one of the most efficient ways to reduce our carbon footprint https://t.co/ggQzWTBnlh

[Konstantin Kisin @KonstantinKisin]

My speech at the Oxford Union is finally available. The debate was "This House Believes Woke Culture Has Gone Too Far".

As promised, I didn't hold back 🤣

[Jean-Marc Holder @jmarcholder]

Breast cancer gene linked to Orkney islands - BBC News https://t.co/Z508cws8qy

[SeqOne @seqonegenomics]

@seqonegenomics and the CNR-MAT are collaborating to investigate leveraging @nanopore #longread technology to better orient treatment of patients suffering from kidney disease while reducing turnaround times. https://t.co/M7Jzpvj5qR
#genomicmedicineforall #genomicmedicine

[Jean-Marc Holder @jmarcholder]

Interesting new approach to cancer treatment https://t.co/0Stasf4lzs

[Jean-Marc Holder @jmarcholder]

Air pollution cancer breakthrough reveals new mechanism that triggers cancers opening the way to new prevention and treatment options - BBC News https://t.co/t0gDgFLM62

[Gilles Babinet @babgi]

Dingue de se dire qu'en baissant son chauffage on évite de financer la Russie et sa guerre d'invasion de l'Ukraine.
Aussi simple que ça.

[@Elaia_Partners @Elaia_Partners]

🎉@seqonegenomics, our portfolio company raises a €20M Series A round ! #ElaiaFamily #PersonalizedGenomicMedicine

🤝 We're super proud to have been by your side for 3 years and counting @nphilippe1684, @jmarcholder & team!

https://t.co/94qkzbtRIq
@EU_Startups @_patriciallen

[@Elaia_Partners @Elaia_Partners]

🙌Delighted to have co-organized the Stayin' Alive event w/ @hellotmrc within the #DeepTechWeek!
Thank you @EGasser @Tilakhealthcare, Mathieu Sanchez @SimAndCure & @jmarcholder @seqonegenomics for sharing your insights & experience about Real World Evidence, Imaging & Big Data🧑‍🔬

[Jean-Marc Holder @jmarcholder]

https://t.co/EKzaNDTWeT

[Yann Lechelle @ylechelle]

GAFAM > GAMMA ?

[Jean-Marc Holder @jmarcholder]

Our investor's view of the fast-moving Digital Life Sciences segment. We are thrilled to have an investor who "gets" the space as well as the @Elaia_Partners team!

https://t.co/CxZ2S3cVc5

[Jean-Marc Holder @jmarcholder]

Crispr gene-editing ‘revolution’ treats internal organ for first time via @FT
https://t.co/62EkZQuI30

[La Tribune Evénements @latribuneevents]

#FSIMontpellier - " Si on arrive plus facilement à commercialiser des technologies développées en France auprès du marché national, on peut envisager ensuite une expansion internationale. "
@jmarcholder @seqonegenomics

[Jean-Marc Holder @jmarcholder]

Disappointing outcome to a large-scale variant cancer screening trial outlines work remains in understanding cancer. https://t.co/wBlCSqJPDI

[Jean-Marc Holder @jmarcholder]

Amazing insights into the genomic work that went into a COVID vaccine. https://t.co/Vly9rpt157

[SeqOne @seqonegenomics]

Recherche médicale : la ministre aujourd’hui à Montpellier https://t.co/CYkPQA8cCw

[SeqOne @seqonegenomics]

SeqOne announces a new, high-volume COVID 19 screening analytics solution for NGS built on our cloud-based genomics platform. It can be deployed in a matter of days and integrates with lab IT and sequencers for improved efficiency. #COVID__19 https://t.co/NAYgenHrGv

[Jean-Marc Holder @jmarcholder]

Coronavirus: The Hammer and the Dance by @tomaspueyo https://t.co/TNbjqxkcnQ